文献

J-GLOBAL ID：201702283003284331   整理番号：17A0681582

ホモ接合家族性高コレステロール血症の日本人患者におけるロミタピドの有効性と安全性

Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia

著者 (8件)： Harada-Shiba Mariko (National Cerebral and Cardiovascular Research Center) ,  Ikewaki Katsunori (National Defense Medical College) ,  Nohara Atsushi (Kanazawa University Graduate School of Medical Sciences) ,  Otsubo Yoshihiko (Shin-Koga Clinic, Medical Group Tenjin-kai) ,  Yanagi Koji (Kenporen Osaka Central Hospital) ,  Yoshida Masayuki (Tokyo Medical and Dental University) ,  Chang Qing (Aegerion Pharmaceuticals, Inc.) ,  Foulds Pamela (Aegerion Pharmaceuticals, Inc.)
資料名： Journal of Atherosclerosis and Thrombosis (Web)  (Journal of Atherosclerosis and Thrombosis (Web))
巻： 24  号： 4  ページ： 402-411(J-STAGE)  発行年： 2017年 
JST資料番号： U0153A  ISSN： 1880-3873  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 目的:50%または100mg/dLへの低密度リポタンパク質コ...

シソーラス用語： ヒト ,...
準シソーラス用語： *ホモ接合型家族性高コレステロール血症 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0681582&from=J-GLOBAL&jstjournalNo=U0153A") }}

著者キーワード (4件)： Homozygous familial hypercholesterolemia ,  Lomitapide ,  Hypercholesterolemia ,  LDL-C

分類 (1件)： 代謝異常・栄養性疾患の治療  (GD05030F)

物質索引 (1件)： ロミタピド

引用文献 (29件)：

• 1) Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, Kuivenhoven JA, Nordestgaard BG, Descamps OS, Steinhagen-Thiessen E, Tybjaerg-Hansen A, Watts GF, Averna M, Boileau C, Boren J, Catapano AL, Defesche JC, Hovingh GK, Humphries SE, Kovanen PT, Masana L, Pajukanta P, Parhofer KG, Ray KK, Stalenhoef AF, Stroes E, Taskinen MR, Wiegman A, Wiklund O, Chapman MJ: Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J, 2014; 35: 2146-2157
• 2) Beigel R, Beigel Y: Homozygous familial hypercholesterolemia: long term clinical course and plasma exchange therapy for two individual patients and review of the literature. J Clin Apher, 2009; 24: 219-224
• 3) Hobbs HH, Brown MS, Goldstein JL: Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat, 1992; 1: 445-466
• 4) Kolansky DM, Cuchel M, Clark BJ, Paridon S, McCrindle BW, Wiegers SE, Araujo L, Vohra Y, Defesche JC, Wilson JM, Rader DJ: Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia. Am J Cardiol, 2008; 102: 1438-1443
• 5) Gidding SS, Ann Champagne M, de Ferranti SD, Defesche J, Ito MK, Knowles JW, McCrindle B, Raal F, Rader D, Santos RD, Lopes-Virella M, Watts GF, Wierzbicki AS, and on behalf of the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and Council on Lifestyle and Cardiometabolic Health: The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association. Circulation, 2015; 132: 2167-2192

タイトルに関連する用語 (7件)： ホモ接合 ,  家族性高コレステロール血症 ,  日本人 ,  患者 ,  ロミタピド ,  有効性 ,  安全性